Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies
Immune Engaging Molecules in the Management of Lymphoid Malignancies
View Workshop (ASH registration required)
Program
Current Results with BITEs and Bispecific Antibodies in Lymphoid Malignancies
Max S. Topp MD
Universitätsklinikum Würzburg
BIKEs TRIKEs and SMITEs
Jeffrey S. Miller MD
University of Minnesota
CD19 Antibodies and CD79-Directed ADCs in B-cell Malignancies
Laurie H. Sehn MD MPH
BCCancer and The University of British Columbia
Immune Engaging Molecules in the Management of Lymphoid Malignancies
Stephen M. Ansell MD PhD
Mayo Clinic
Immune Engaging Molecules in the Management of Lymphoid Malignancies
Ronald Levy MD
Stanford University Medical Center